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ABSTRACT
Objectives This study aimed to explore the relationship 
(presence and severity) between chronic breathlessness 
and sleep problems, independently of diagnoses and 
health service contact by surveying a large, representative 
sample of the general population.
Setting Analysis of the 2017 South Australian Health 
Omnibus Survey, an annual, cross- sectional, face- to- face, 
multistage, clustered area systematic sampling survey 
carried out in Spring 2017.
Chronic breathlessness was self- reported using the 
ordinal modified Medical Research Council (mMRC; scores 
0 (none) to 4 (housebound)) where breathlessness has 
been present for more than 3 of the previous 6 months. 
‘Sleep problems—ever’ and ‘sleep problem—current’ 
were assessed dichotomously. Regression models were 
adjusted for age; sex and body mass index (BMI).
Results 2900 responses were available (mean age 
48.2 years (SD=18.6); 51% were female; mean BMI 
27. 1 (SD=5.9)). Prevalence was: 2.7% (n=78) sleep 
problems—past; 6.8% (n=198) sleep problems—current 
and breathlessness (mMRC 1–4) was 8.8% (n=254). 
Respondents with sleep problemspast were more likely 
to be breathless, older with a higher BMI and sleep 
problems—present also included a higher likelihood of 
being female.
After adjusting for age, sex and BMI, respondents with 
chronic breathlessness had 1.9 (95% CI=1.0 to 3.5) times 
the odds of sleep problems—past and sleep problems—
current (adjusted OR=2.3; 95% CI=1.6 to 3.3).
Conclusions There is a strong association between 
the two prevalent conditions. Future work will seek to 
understand if there is a causal relationship using validated 
sleep assessment tools and whether better managing one 
condition improves the other.
INTRODUCTION
Chronic breathlessness is highly prevalent. It 
affects up to 8% of the adult population in 
high- income countries1–3 and is associated 
with impaired physical and mental quality of 
life,4 increased levels of anxiety and depres-
sion,5 decreased levels of sexual activity in 
the elderly,6 increased social isolation7 8 and 
poorer prognosis.9 10 Unlike many symptoms, 
chronic breathlessness often worsens late in 
life.11
Similarly, impaired sleep quality and 
insomnia are prevalent across the community, 
even in the absence of obstructive sleep 
apnoea (OSA).12–14 Up to 40% of people with 
OSA will also have symptomatic insomnia.15 
Poor sleep quality and insomnia are associ-
ated with worse physical and mental quality of 
life,16 anxiety and depression,17–19 less satisfac-
tion with sexual function in postmenopausal 
women19 20 and poorer life expectancy.21 Both 
chronic breathlessness and poor sleep quality 
are more common in the elderly.4 13
Associations in the general population, 
without relying on contact with health 
services, between chronic breathlessness 
(irrespective of the underlying aetiologies) 
and sleep problems have not been defined. 
Understanding this relationship is important 
given the high burden of these conditions, 
the complex relationship between them and 
the ability to explore changing the symptom-
atic course of both by ameliorating either one 
of them.
By asking a broad sample of randomly 
selected members of the public about their 
chronic breathlessness and sleep problems, 
key clinical and demographic factors can be 
defined for the first time. Further, if there 
is a relationship between worsening chronic 
breathlessness and the presence of sleep 
problems, intervention studies to improve 
sleep may be beneficial in the management 
of chronic breathlessness and vice versa.
Strengths and limitations of this study
 ► This was a large, random survey of the population 
using trained interviewers in face- to- face inter-
views, irrespective of health service contact.
 ► The survey used tools that were designed for popu-
lation survey use.
 ► This study can only reflect associations, not cause 
and effect.
 ► The data on chronic breathlessness and sleep 
problems were based on self- report, not clinical 
assessments.
 ► The data are cross- sectional, not longitudinal.
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The aim of this study was to evaluate the association 
between the presence and severity of chronic breathless-
ness and self- reported sleep problems.
METHODS
Survey design
This was an analysis of the 2017 South Australian Health 
Omnibus Survey (online supplemental appendix 1),3 22 
an annual, cross- sectional, face- to- face, multistage, clus-
tered area systematic sampling survey. It was run by a 
commercial research organisation, providing deidenti-
fied data for user- pays researchers. Approximately 200 
questions (including different questions on symptoms, 
self- reported conditions and health service utilisation) 
were asked annually. Each year, demographic questions 
remained relatively unchanged.
Data were collected through interviews in partici-
pants’ homes by trained interviewers, lasting 60–90 min. 
Members of the public were therefore engaged, inde-
pendently of health service contact. The methodology 
has been described previously in detail.22 23
Setting and participants
South Australia is the second smallest state by population in 
Australia, with a population of approximately 1.73 million 
people (6.9% of the Australian population), mostly living 
in Adelaide, the state’s capital.24 The survey was carried 
out between September and December each year having 
been piloted with 50 residents from the general commu-
nity annually. A stratified sampling method identified a 
representative cohort from metropolitan and rural towns 
with populations of more than 1000. More than 5000 
properties were approached annually.
Two randomisations occurred during the sampling 
process: (1) by census collector districts (CCDs) and 
(2) starting points within each randomly selected CCDs. 
From the starting point in each CCD, a skip pattern of 
every tenth property was used to select the next property. 
Properties approached included houses, businesses, prop-
erties with other uses or vacant land. Hotels, hospitals, 
caravan parks and aged care facilities were not sampled. 
When houses were identified, interviewers would return 
up to six times if contact could not be made with the 
household initially. Participation rates were calculated 
on the number of potential participants with whom any 
contact was made.
One interview was conducted in each household with 
the person aged ≥15 years who most recently had a 
birthday. If that person was unwilling to participate and 
another member of the household was unable to replace 
him/her, then that household was classified as declining 
participation.
Data quality
All data were double entered, with a supervisor following 
up missing responses by telephone. Additionally, 10% 
of each interviewer’s respondents were recontacted 
to confirm their eligibility and ensure consistency of 
responses by reanswering a selection of questions. Data 
were anonymised and then released to researchers for 
analysis.
An initial total of 2977 people were engaged with the 
interviews with an overall participation rate of 65.3%, of 
whom 2900 were 18 years or older and were included in 
the analysis. All eligible respondents were included to 
maximise power and minimise bias. For the purposes of 
this study, analyses were restricted to participants 18 years 
and older who answered questions related to breathless-
ness and sleep problems (n=2900). As the rate of missing 
data was low for all variables except body mass index 
(BMI; 5.9%), no data were imputed.
Exposure variable
Breathlessness was self- reported using the modified 
Medical Research Council (mMRC)25 Scale to the ques-
tion ‘thinking back over the last 6 months, have you had 
an episode of breathlessness that has lasted more than 
3 months’. This timeframe was an arbitrary period used 
in previous population studies to assess a degree of chro-
nicity.11 Response categories included 0=None; 1=‘I get 
short of breath when hurrying on the level or up a slight 
hill’; 2=‘I have to stop for breath when walking at my own 
pace on the level’; 3=‘I stop for breath after walking 100 
meters or after a few minutes on the level’ or 4=‘I am too 
breathless to leave the house’. mMRC is reliable, valid and 
the most commonly used scale for categorising the func-
tional impact and disability from breathlessness in daily 
life.26 27 For the purpose of analysis, breathlessness was 
defined as an mMRC ≥1. Additional analyses were under-
taken to examine the severity of breathlessness using all 
mMRC categories (0–4) as an ordinal scale.
Outcome
‘Sleep problems—ever’ was assessed with the item (yes/
no): ‘Has a doctor ever told you that you had insomnia or 
some sleep problem?’ Two questions ‘Are you currently 
taking medication for insomnia or some sleep problem?’ 
and ‘Have you seen a doctor in the last 6 months for 
insomnia or some sleep problem?’ were combined to 
assess ‘sleep problems—current’ with ‘yes’ to either 
coding as a positive response. The study reports sleep 
problems—past by subtracting sleep problems—current 
from sleep problems—ever.
Measures
Sociodemographic data were collected on age, sex, rurality 
(metropolitan, non- metropolitan), country of birth 
(Australia, UK/Ireland, other), marital status (married/
de facto, separated/divorced, widowed, never married), 
highest level of educational attainment (secondary, 
trade/apprenticeship/certificate/diploma, degree or 
higher) and postcode. The postcodes were linked to the 
Socio- Economic Index for Areas (SEIFA). SEIFA is used to 
rank areas according to socioeconomic advantage/ disad-
vantage (eg, wealth, occupation and education) derived 
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from Australian national census data.28 For the purpose 
of this study, SEIFA was based on ranking derived from 
2016 census data and was categorised into a quintiles. 
BMI (kg/m2) was calculated from self- reported height 
and weight. In addition to including BMI as a continuous 
measure, it was categorised according to international 
criteria—underweight/normal: ≤24.9, overweight: 25.0–
29.9 and obese: ≥30.0.29
Statistical analysis
Data were weighted to the 2016 Estimated Residential 
Population for South Australia by 5- year age groups, sex, 
rurality and household size derived from the Australian 
census conducted that year.
Data analyses were conducted using SPSS for Windows 
V.26.0. (2011). Respondents’ demographic character-
istics were tabulated by sleep problems—ever. Bivariate 
Table 1 Demographic and clinical baseline data for respondents to the 2017 South Australian Health Omnibus Survey by 
response to past and current sleep problems (weighted total=2900)









Age*, mean(SD) 54.3 (16.6) 48.1 (18.6) 0.002 51.5 (18.5) 48.0 (18.6) 0.01
Sex* 0.7 0.001
  Male 40 (51.3) 1380 (48.9) 74 (37.4) 1346 (49.8)
  Female 38 (48.7) 1442 (51.1) 124 (62.6) 1356 (50.2)
Breathlessness 0.008 <0.001
  mMRC=0 65 (83.3) 2581 (91.5) 160 (81.2) 2485 (92)
  mMRC ≥1 13 (16.7) 241 (8.5) 37 (18.8) 217 (8)
Body mass index (BMI)* categories 0.09 0.001
  <25 30 (39.5) 1061 (40) 60 (31.6) 1031 (40.6)
  25–30 20 (26.3) 951 (35.8) 62 (32.6) 908 (35.7)
  >30 26 (34.2) 642 (24.2) 67 (35.3) 601 (23.7)
  BMI (kg/m2); mean (SD) 27.8 (6.1) 27.1 (5.9) 0.3 28.6 (6.9) 27.0 (5.8) 0.003
Rurality 0.4 0.4
  Metropolitan 61 (78.2) 2094 (74.2) 152 (76.8) 2003 (74.1)
  Non- metropolitan 17 (21.8) 728 (25.8) 46 (23.2) 699 (25.9)
Socio- Economic Indexes for Area quintile 0.4 0.2
  1 Most disadvantaged 13 (16.7) 718 (25.4) 56 (28.3) 675 (25)
  2 – 11 (14.1) 416 (14.7) 31 (15.7) 396 (14.7)
  3 – 18 (23.1) 524 (18.6) 37 (18.7) 505 (18.7)
  4 – 18 (23.1) 645 (22.9) 49 (24.7) 614 (22.7)
  5 Most advantaged 18 (23.1) 519 (18.4) 25 (12.6) 512 (18.9)
Country of birth 0.03 0.03
  Australia 61 (78.2) 2030 (71.9) 143 (72.2) 1948 (72.1)
  UK/Ireland 10 (12.8) 247 (8.8) 27 (13.6) 230 (8.5)
  Other 7 (9) 545 (19.3) 28 (14.1) 523 (19.4)
Highest level of educational attainment 0.7 0.01
  Up to a secondary 27 (34.6) 1012 (35.9) 80 (40.4) 959 (35.5)
  Trade, apprenticeship, certificate, diploma 33 (42.3) 1075 (38.1) 84 (42.4) 1024 (37.9)
  Degree or higher 18 (23.1) 732 (25.9) 34 (17.2) 716 (26.5)
Marital status* 0.01 <0.001
  Married/de facto 43 (55.1) 1794 (63.6) 92 (46.5) 1745 (64.6)
  Separated, divorced 14 (17.9) 249 (8.8) 42 (21.2) 222 (8.2)
  Widowed 8 (10.3) 154 (5.5) 19 (9.6) 143 (5.3)
  Never married 13 (16.7) 622 (22.1) 45 (22.7) 590 (21.9)
*Missing values.
mMRC, Modified Medical Research Council Scale.
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associations of ‘sleep problems—ever’ with sociodemo-
graphic factors were analysed using Pearson’s χ2 tests for 
categorical variables and for continuous data indepen-
dent sample t- tests.
The association between chronic breathlessness and 
sleep problem indicators was analysed using multiple 
logistic regression, adjusted for the potential confounders 
age, sex and BMI. Variables to adjust for were selected 
based on subject matter knowledge and the literature.30 
Age and BMI were included as continuous variables and 
the assumption of linearity in their logits was assessed 
using Box Tidwell Test.31 The two- way interaction terms 
were also assessed for significance. The goodness of fit 
was evaluated using the Hosmer- Lemeshow Test. Associ-
ations were expressed as OR with 95% CI. The Mantel- 
Haenszel linear- by- linear association χ2 test was used to 
detect the linear trend between severity of breathlessness 
(mMRC 0–4) and sleep problem indicators. P≤0.05 was 
considered statistically significant. A sensitivity analysis 
using unweighted data was performed to evaluate the 
robustness of the findings.
Ethics approval, consent and reporting
The study was approved annually by the Human Research 
Ethics Committee of the South Australian Depart-
ment of Health and the University of Adelaide Human 
Research Ethics Committee (H-097–2010). Informed 
verbal consent was obtained from each participant and 
continued participation accepted as ongoing consent. 
The study is reported in compliance with the STROBE 
checklist for cross- sectional studies.32
RESULTS
Initially, 2977 people were engaged with the interviews 
with an overall participation rate of 65.3%, of whom 2900 
were 18 years or older and answered the key questions 
on breathlessness and sleep. In the total respondent 
sample, the mean age was 48.2 years (SD=18.6) and 51% 
(n=1480) were females. Mean BMI was 27. 1 (SD=5.9). 
The prevalence was 2.7% (n=78) for sleep problems—
past and 6.8% (n=198) for sleep problems—current. The 
overall prevalence of breathlessness (mMRC 1–4) was 
8.8% (n=254). Respondents with sleep problems—past 
were more likely to be breathless, older and with a higher 
BMI. Respondents with sleep problems—current were 
also more likely to be female. These factors were taken 
into the regression models. (table 1)
After adjusting for age, sex and BMI, breathlessness 
was strongly associated with sleep problems—past and 
also sleep problems—current. Respondents with chronic 
breathlessness had 1.9 (95% CI=1.0 to 3.5; table 2) times 
the odds of sleep problems—past than those without 
breathlessness. The association between breathless-
ness and sleep problems—current was similar (adjusted 
OR=2.3; 95% CI=1.6 to 3.3; table 2). No interaction terms 
were significant in the adjusted analysis.
Mantel- Haenszel χ2 tests demonstrated significant 
linear- by- linear associations between chronic breathless-
ness (mMRC 0–4) and sleep problems—past (p<0.001) 
and sleep problems—current (p<0.001). The prevalence 
of sleep problems—ever or current generally increased 
with severity of breathlessness as measured with mMRC 
(0–4; figure 1).
The sensitivity analysis of the unweighted data demon-
strated similar associations between breathlessness and 
sleep problems, supporting the robustness of the models.
DISCUSSION
In a random adult population sample, this study found a 
strong association between the presence of chronic breath-
lessness and insomnia or sleep problems. These findings 
complement previous findings that have sampled specific 
disease states that may be associated with chronic breath-
lessness such as chronic obstructive pulmonary disease 
(COPD), interstitial lung disease or cardiac failure.33
Two in three people responding to Omnibus surveys 
who identified symptomatic chronic breathlessness iden-
tified respiratory causes for their chronic breathlessness.33 
Sleep problems and breathlessness are both prevalent in 
people with COPD, with both problems impacting on 
quality of life.34–39 One study of 51 patients with COPD 
found no relationship between sleep measures (Pitts-
burgh Sleep Quality Index (PSQI), Epworth Sleepiness 
Scale) polygraphic sleep studies and mMRC breathless-
ness scales.36 Another study of 130 people with COPD 
sought to generate symptom clusters, one of which was 
sleep disturbance and fatigue.37 In another case series of 
60 patients with COPD, poor sleep quality and impaired 
health- related quality of life were highly correlated and 
in the regression analysis, sleep quality was the strongest 
predictor of quality of life.40
Other causes of chronic breathlessness include 
malignancy. In 128 people with advanced lung cancer, 
there was a strong correlation between the severity 
of respiratory symptoms and the likelihood of sleep 
Table 2 OR and adjusted OR of sleep problems—ever and 
sleep problems—current by level of chronic breathlessness 






OR (95% CI) aOR* (95% CI)
Past
  mMRC=0 Reference
  mMRC ≥1 2.3 (1.3 to 4.1) 1.9 (1.0 to 3.5)
Current
  mMRC=0 Reference
  mMRC ≥1 2.7 (1.9 to 3.8) 2.3 (1.6 to 3.3)
*Having adjusted for age (years), sex and body mass index (kg/
m2).
mMRC, modified Medical Research Council Scale.
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disturbance (measured with the PSQI) and poor quality 
of life (measured with Functional Assessment of Cancer 
Therapy- Lung.36 In another series of 115 people with lung 
cancer undergoing chemotherapy, sleep disturbance was 
strongly associated with poorer functional status and 
poorer cognition.40
Strengths
This is a survey of a random selection of the general 
population not limited by contact with health services. 
The dataset was standardised to a census- defined national 
population. The study builds on previous work defining 
rates of self- reported levels of exertion limited by breath-
lessness.3 10 41 These rates are surprisingly stable across the 
population.
Limitations
There is an association between breathlessness and sleep 
problems, but the dynamics of this relationship (which 
comes first, which problem is dominant) cannot be defined 
from this study. Having found this strong signal, this will be 
the subject of future studies. More detailed clinical histories 
related to sleep are required as are laboratory sleep studies 
to understand the interaction between chronic breathless-
ness and specific sleep problems including insomnia. For 
example, the current study questions cannot distinguish 
between common sleep disorders such as insomnia and 
sleep apnoea. This preliminary exploration would strongly 
justify more in- depth population analyses comprising clin-
ical and physiological data. The mMRC only provides a 
broad- brush picture of the level of exertion required before 
breathlessness supervenes. Multidimensional tools such as 
the Dyspnoea-12 or the Multidimensional Dyspnea Profile 
would allow a more detailed exploration of the aspects 
of breathlessness that most strongly impact insomnia 
and sleep disturbances.42 This preliminary study seeking 
to explore the relationship between sleep problems and 
chronic breathlessness in face- to- face interviews covering a 
very wide range of health topics has shown a relationship 
in univariate and multivariate analyses that now justifies 
progressing to a population study using validated tools for 
the assessment of sleep and chronic breathlessness. Vali-
dated and standardised tools such as the PSQI can now be 
justified in future study design and funding applications43 
in order to reliably categorise individuals with sleep prob-
lems. Given that these are observational data, findings 
can only be interpreted as associations and not cause and 
effect. Future work could include seeking permission to 
contact respondents’ treating clinicians or even extend to 
formal sleep studies for a subgroup of respondents that 
identify current sleep problems.
The relationship between the more severe levels of 
breathlessness and sleep problems is not statistically signif-
icant and almost certainly relates to the power achieved 
in the study because of low prevalence of severe and very 
severe breathlessness.
Implications for future research
Understanding whether people had long- term sleep 
problems and developed breathlessness with worsening 
Figure 1 Prevalence of past and current sleep problems by level of chronic breathlessness in a random sample of the 
population of South Australia (n=2898). mMRC, modified Medical Research Council breathlessness scale.
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COPD in later life, vice versa or a mixture of both will be 
important.
A before- and- after study of pulmonary rehabilitation in 
people with COPD demonstrated improvements in sleep 
quality measured on the PSQI and in breathlessness after 
8 weeks of outpatient pulmonary rehabilitation.44 Such 
findings suggest that improving one symptom may have 
measurable collateral benefits with other long- standing 
symptoms. Future studies focusing on improving sleep 
may provide insights into better symptom control and the 
mechanisms of sleep disturbance.
Conversely, at least one double- blind, placebo- 
controlled crossover randomised trial has shown that 
when symptomatic breathlessness is reduced successfully, 
perceived sleep improves.45 This observation needs to be 
explored in a much larger study with individuals partic-
ipating in the study for longer than the 8 days reported 
in the study by Martins et al. Such work should include 
formal sleep studies at least in a subgroup of participants.
Implications for clinical care
Notwithstanding the further research that needs to be 
done, these data suggest that clinicians should enquire 
about sleep health when they identify someone with 
chronic breathlessness and vice versa. This is especially the 
case for people with more severe chronic breathlessness.
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